Luca Cardone
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
Journal: Cancer management and research
Published: August 29, 2024
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors.
Journal: iScience
Published: June 27, 2024
Cancer incidence (2000-2020) among individuals under 35: an emerging sex disparity in oncology.
Journal: BMC medicine
Published: March 09, 2024
DNA demethylation triggers cell free DNA release in colorectal cancer cells.
Journal: Genome medicine
Published: July 31, 2023
Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers.
Journal: International journal of molecular sciences
Published: June 15, 2020
Boosting the arsenal against COVID-19 through computational drug repurposing.
Journal: Drug discovery today
Published: March 29, 2020
Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Journal: Seminars in cancer biology
Published: August 01, 2019
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism.
Journal: Cancer research
Published: April 24, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research
Published: January 17, 2019
Drug repurposing for the treatment of glioblastoma multiforme.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 09, 2017
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Journal: Oncotarget
Published: January 03, 2016
Last Updated: 09/26/2026